Provider
QP55-22 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2022
Program effective Date: Jul 13, 2022
Search Results
Displaying 1791 - 1800 of 3770 results
Provider
QP56-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Cibinqo™ (abrocitinib)
Program effective Date: Jul 13, 2022
Provider
QP57-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Pyrukynd® (mitapivat)
Program effective Date: Jul 13, 2022
Provider
QP58-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Recorlev® (levoketoconazole)
Program effective Date: Jul 13, 2022
Provider
QP59-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Tarpeyo™ (budesonide)
Program effective Date: Jul 13, 2022
Provider
QP60-22 MHCP Pharmacy Benefit Exclusion for Camcevi™ (leuprolide)
Program effective Date: Jul 13, 2022
Provider
CMV Oral - Commercial
Quantity Limit
Program effective Date: Apr 01, 2025
Provider
QP52-22 Learn to Live – An Online Behavioral Health Resource for Select Blue Cross and Blue Shield of Minnesota Health Plan Members
Program effective Date: Jun 22, 2022
Provider
QP54-22 Update for New to Market Medical Drugs: betibeglogene autotemcel
Program effective Date: Jun 22, 2022
Provider
QP61-22 Free Continuing Education for Mental Health Providers through 12/31/22
Program effective Date: Jul 27, 2022